|
|
|
40
|
22814
|
ACETAZOLAMIDE 250MG TAB (REM/SBI)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
1000's
|
A
|
84.43
|
0.08
|
TABLET
|
120
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
22814
|
ACETAZOLAMIDE 250MG TAB (REM)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
1000'S
|
A
|
107.4
|
0.1074
|
TAB
|
120
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
22814
|
ACETAZOLAMIDE 250MG TAB (REM)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
1000'S
|
A
|
105.74
|
0.11
|
TAB
|
120
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
40
|
22819
|
ACETAZOLAMIDE 250MG TAB (KWA/ATB)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
10X10
|
A
|
80.79
|
0.08
|
TABLET
|
120
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
2022-03-30
|
|
|
|
40
|
2281AA
|
ACETAZOLAMIDE 250MG TAB (FSB/ATB)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
10X10
|
A
|
7.20
|
0.07
|
TABLET
|
120
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
2281AS
|
APO-ACETAZOLAMIDE 250MG TAB (APO)
|
ACETAZOLAMIDE
|
APO-ACETAZOLAMIDE
|
100'S
|
A
|
12.01
|
0.1202
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
2281AU
|
ACETAZOLAMIDE 250MG TAB (FSB)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
1000'S
|
A
|
55.54
|
0.06
|
TAB
|
120
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-03-05
|
|
|
|
42
|
2281U
|
ACEMIDE 250MG TAB (JLP) ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
ACEMIDE
|
100'S
|
A
|
8.16
|
0.08
|
TAB
|
120
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
40
|
22826
|
ACETAZOLAMIDE 500MG INJ (XGE/AHI)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
1DOSE SYRN
|
BQ
|
165.44
|
165.44
|
INJECTION
|
0
|
PFS
|
XGE
|
X-GEN PHARMACEUTICALS INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
2022-03-29
|
|
|
|
40
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT/AHI)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
182.67
|
182.67
|
INJECTION
|
0
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
182.89
|
182.8888
|
VIAL
|
10
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
22827
|
ACETAZOLAMIDE 500MG INJ (MAT)
|
ACETAZOLAMIDE
|
ACETAZOLAMIDE
|
500MG VIAL
|
BQ
|
189.39
|
189.39
|
VIAL
|
10
|
VIAL
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
40
|
22832
|
ACETAZOLAMIDE SR 250MG TAB (CHC/ATB)
|
ACETAZOLAMIDE SR
|
ACETAZOLAMIDE SR
|
100'S
|
A
|
154.75
|
1.55
|
TABLET
|
60
|
TAB
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
23012
|
OXYBUPROCAINE MINIMS 0.4% EYE DR (CAM) (B)
|
OXYBUPROCAINE
|
OXYBUPROCAINE MINIMS
|
20X0.5ML
|
B
|
82.53
|
4.1264
|
BOX
|
4
|
AMPP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5216
|
EENT LOCAL ANESTHETIC
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT LOCAL ANESTHETIC
|
|
|
|
|
40
|
23016
|
OXYBUPROCAINE MINIMS 0.4% EYE DR (CAM/STO)
|
OXYBUPROCAINE
|
OXYBUPROCAINE MINIMS
|
20X0.5ML
|
B
|
94.73
|
4.74
|
EYE DROP
|
0
|
AMP
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
5216
|
EENT LOCAL ANESTHETIC
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
23132
|
MIOSTAT OCULAR 0.01% INJ (ALC/AHI) CARBACHOL
|
CARBACHOL
|
MIOSTAT OCULAR
|
1.5ML VIAL
|
BQ
|
59.94
|
59.94
|
INJECTION
|
0
|
VIAL
|
ALC
|
ALCON LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
524020
|
EENT MIOTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
23132
|
MIOSTAT OCULAR 0.01% INJ (ALC) CARBACHOL
|
CARBACHOL
|
MIOSTAT OCULAR
|
1.5ML VIAL
|
BQ
|
55.18
|
55.182
|
VIAL
|
0
|
VIAL
|
ALC
|
ALCON LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
524020
|
EENT MIOTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
EENT MIOTICS
|
|
|
|
|
42
|
23132
|
MIOSTAT OCULAR 0.01% INJ (ALC) CARBACHOL
|
CARBACHOL
|
MIOSTAT OCULAR
|
1.5ML VIAL
|
BQ
|
52.95
|
52.95
|
VIAL
|
0
|
VIAL
|
ALC
|
ALCON LABORATORIES INC.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
524020
|
EENT MIOTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
EENT MIOTICS
|
|
|
|
|
42
|
23312
|
PILOCARPINE 2% EYE DR (MTP)
|
PILOCARPINE
|
PILOCARPINE
|
10ML
|
A
|
33.49
|
33.49
|
BOTT
|
1
|
BOTT
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524020
|
EENT MIOTICS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT MIOTICS
|
|
|
|
|
40
|
2331J
|
PILOCARPINE 2% EYE DR (MTP/COL)
|
PILOCARPINE
|
PILOCARPINE
|
10ML
|
A
|
15.25
|
15.25
|
EYE DROP
|
1
|
BOTT
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
B
|
524020
|
EENT MIOTICS
|
2022-04-01
|
2024-03-31
|
Price Change
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-18
|